PORTFOLIO AUTOPSY RISK TERMINAL
Home › Drawdowns › IBB
Drawdown history · ETF

IBB’s worst drop since 2001 was 63%

iShares Biotechnology ETF (IBB) fell 63% from Jun 2001 to Jul 2002. It took 9.9 years from that peak to close at a new high, in Apr 2011. Over the same years the S&P 500 fell as much as 55%.

That drop ranks 52nd deepest among the 203 ETFs PortfolioAutopsy tracks.

−62.9%
Worst drop
Jun 2001 → Jul 2002
9.9 yrs
Back to the old high
new high Apr 2011
−59.3%
Worst 12 months
Jul 2001 → Jul 2002
9.9 yrs
Longest underwater
from Jun 2001
−7.8%
Now vs its high
as of 2026-10-13
+7.3%
Yearly return since 2001
dividends reinvested

Drawdown from the last high, 2001 to now

IBBS&P 500 (SPY)
IBB drawdown from its last high since 20010%−20%−40%−60%20052010201520202025−63% by Jul 2002

How IBB held up in each crash

CrashYearsIBBS&P 500
Dot-com bust2000–02not trading yet−47.5%
Financial crisis2007–09−34.6%−55.2%
COVID crash2020−23.6%−33.7%
2022 rate shock2022−30.4%−24.5%

Each number is the deepest fall from a high inside that window, using daily prices with dividends reinvested.

Your portfolio is more than one ticker.

See how IBB behaves inside your whole mix, with the worst 12 months, loss odds and crash replays. Free, no signup, and the math runs in your browser.

Open IBB in PortfolioAutopsyCheck my whole portfolio

Questions

What was IBB’s maximum drawdown?

IBB’s deepest fall since 2001 was 62.9%, from its high on June 5, 2001 to its low on July 10, 2002. The figure uses daily prices with dividends reinvested.

How long did IBB take to recover?

9.9 years. IBB first closed above its Jun 2001 high again on April 27, 2011.

Was IBB riskier than the S&P 500?

Over the same years, IBB’s worst drop was 62.9% against 55.2% for the S&P 500 (SPY), and its worst 12 months were −59.3% against −47.4%.

Compare with

MCHI −63%DVY −63%IUSG −63%XLI −62%VIS −64%VGK −64%VBR −62%XBI −64%All tickers

Daily adjusted closes from Yahoo Finance, February 13, 2001 through October 13, 2026, dividends reinvested. Historical facts, not a forecast and not investment advice.

Run a free risk checkDrawdown tableStudyAboutPrivacyTerms